JEPQ vs VHT
JPMorgan Nasdaq Equity Premium Income ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.35% for JEPQ.
- • JEPQ pays a higher dividend yield (9.95%).
Side-by-side metrics
| Metric | JEPQ | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.09% |
Dividend yield Trailing 12-month yield. | 9.95% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $40.66B | $20.39B |
YTD return | 8.22% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.78 | 0.57 |
P/E ratio | 31.92 | 26.46 |
Last price | $60.24 | $306.54 |
Inception | — | — |
Issuer | JPMorgan | Vanguard |
JEPQ top holdings
| NVDA | NVIDIA Corp | 6.62% |
| AAPL | Apple Inc | 5.77% |
| MU | Micron Technology Inc | 5.53% |
| GOOG | Alphabet Inc Class C | 5.00% |
| MSFT | Microsoft Corp | 3.86% |
| AMD | Advanced Micro Devices Inc | 3.83% |
| AMZN | Amazon.com Inc | 3.64% |
| LRCX | Lam Research Corp | 2.86% |
| TSLA | Tesla Inc | 2.37% |
| META | Meta Platforms Inc Class A | 2.36% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About JEPQ
JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) is Nasdaq-tilted equity income with options overlay. Managed by JPMorgan, the fund carries $40.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 9.95%. Its largest holding is NVIDIA Corp (NVDA), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.